HR3906-119

2. Restoration of amounts for Defense Health Agency research, development, test, and evaluation Section 1407(1) of the Full-Year Continuing Appropriations and Extensions Act, 2025 (Public Law 119–4) is amended— by striking $40,395,072,000 and inserting $41,576,684,000; and by striking the 23rd comma and all that follows through the period at the end and inserting a period. The amendments made by subsection (a) shall take effect as if included in the enactment of the Full-Year Continuing Appropriations and Extensions Act, 2025 (Public Law 119–4). The funds made available for Congressionally Directed Medical Research Programs pursuant to section 1407(1) of the Full-Year Continuing Appropriations and Extensions Act, 2025 (Public Law 119–4), as amended by subsection (a), shall be implemented in levels and in a manner consistent with the Consolidated Appropriations Act, 2024 (Public Law 118–47). The Secretary of Defense shall— ensure that such funds are used to support all research programs, peer-reviewed initiatives, and projects identified in the explanatory statement accompanying the Consolidated Appropriations Act, 2024 (Public Law 118–47); and obligate and expend such funds in a manner that preserves program continuity, including adherence to all specified funding allocations and research priorities identified on pages 311 through 314 of such explanatory statement.